R. Barry Holtz

Intervexion Therapeutics, Llc

$5,131,048

Attributed

$7,113,116

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY2005–10

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

Funding mix

By agency

NIH$7,113,116 · 2

By mechanism

RC2$3,964,137 · 1

R42$3,148,979 · 1

Top collaborators

W Brooks Gentry2 shared

Most similar at Intervexion Therapeutics, Llc

Same institution · by research overlap

Misty Ward Stevens$38,285,082

Others in their field

Top investigators on “Drug Abuse”

Sten H Vermund · University Of Alabama At Birmingham$115,253,143
Lloyd D Johnston · University Of Michigan At Ann Arbor$107,231,156
Jeffrey H Samet · Boston University Medical Campus$99,970,887
Barbara Driver · Westat, Inc.$95,592,456
T John Winhusen · University Of Cincinnati$74,530,561
Willard Cates · Family Health International$66,963,584

Research focus

Drug AbuseProductionAffinityInvestigational New Drug ApplicationMonoclonal AntibodiesPre-ClinicalClinical TrialsDrug Abuse TherapyIndustryInnovationDesignMedicalCyclic GmpPharmaceutical PreparationsDrug DevelopmentChronicDosePreparationArkansasDrug KineticsAcuteClinical ProtocolsAntibodiesProtocol Development